Skip to main content

Collectrin/TMEM27 Antibody (C6)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-41816

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-41816

Key Product Details

Species Reactivity

Human

Applications

Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2b Kappa Clone # C6

Concentration

1 mg/ml

Product Specifications

Immunogen

Immunized with recombinant Human Collectrin/TMEM27 (Uniprot#: Q9HBJ8; Cys17-Asp137 (Uniprot#: Q9HBJ8)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2b Kappa

Applications for Collectrin/TMEM27 Antibody (C6)

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

5-20ug/mL

Immunohistochemistry

5-20ug/mL

Western Blot

0.01-2ug/mL

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

0.01M PBS, pH7.4, 50% glycerol

Preservative

0.05% Proclin 300

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Collectrin

The Tmem27 gene encodes a transmembrane protein that is important for trafficking amino acid transporters to the apical brushborder of proximal tubules. It also plays a role in controlling insulin exocytosis by regulating formation of theSNARE (soluble N-ethylm

Alternate Names

NX17, TMEM27

Gene Symbol

CLTRN

Additional Collectrin Products

Product Documents for Collectrin/TMEM27 Antibody (C6)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Collectrin/TMEM27 Antibody (C6)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...